Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112778191A details a green photocatalytic route for indole allyl alcohols, offering high yield and mild conditions for reliable pharmaceutical intermediate supply.
Novel chiral phosphoric acid catalyzed synthesis of axially chiral indole-naphthalene compounds. High enantioselectivity, mild conditions, scalable for API manufacturing.
Discover the novel photocatalytic synthesis of heterocyclic cyclopropanes from patent CN112898202B. A mild, high-yield route for pharmaceutical intermediates manufacturing.
Patent CN110105404A reveals a stable ruthenium catalyst enabling green imine synthesis. This technology offers substantial cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel 5,5'-linked biphenyl ligands offering high stereoselectivity. Optimized synthesis for cost-effective pharmaceutical intermediate manufacturing and scalable production.
Novel patent CN116354930B enables efficient tetrahydroquinoline synthesis offering supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing globally.
Novel chiral phosphoric acid catalysis enables high-yield synthesis. Offers cost reduction and supply reliability for antitumor drug intermediates.
Novel synthesis method for axial chiral vinyl indolo compounds. High yield, mild conditions, suitable for pharmaceutical intermediates mass production and supply.
Patent CN114874139A details a green visible-light method for synthesizing 1-benzyl-3,4-dihydroisoquinolines, offering cost-effective routes for pharmaceutical intermediates.
Discover the efficient NHC-catalyzed synthesis of pyrano[3,2-b]indol-2-one intermediates. High yield, mild conditions, and scalable pharmaceutical manufacturing solutions.
Patent CN110452150B details a novel one-step synthesis of axial chiral indole-naphthalenes using chiral phosphoric acid, offering high enantioselectivity and scalable manufacturing for advanced catalytic applications.
Patent CN113307790B reveals a metal-free oxidative cyclization route for bioactive triazoles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel Mo/Cu co-catalyzed method for 3-trifluoromethyl-1,2,4-triazoles. High efficiency, mild conditions, scalable for pharmaceutical intermediates.
Patent CN108456227A reveals visible-light synthesis for high-purity fluorosulfonyl phosphonates. Enables cost reduction and scalable manufacturing for enzyme inhibitors.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high enantioselectivity. Ideal for anticancer drug development and cost-effective API manufacturing.
Patent CN110452150A reveals high-purity axial chiral indole-naphthalene synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable supply.
Patent CN109384794A reveals protic acid catalyzed route. High yield, green chemistry. Reliable supplier for scale-up.
Novel Rh-catalyzed aminocarbonylation using dimethyl carbonate offers a green, high-yield route for acetamide production, ensuring cost-effective supply chain solutions.
Patent CN119320392A details a green catalytic route for Rucaparib. This report analyzes cost reduction in API manufacturing and supply chain reliability for procurement teams.
Novel isoindolinone-derived unsaturated imine synthesis via binaphthyl phosphoric acid. Delivers high yield, scalable production, and cost advantages for pharmaceutical supply chains.